fbpx
Sign up now!
Don't show this again
Sweepstakes Rules

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
X
Share
X
REPORTSCollect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY
follow us


You must be logged in to edit your profile.

Sponsored by Zoetis

Sponsored By Zoetis

.
PHTweb GM Vaccine Ss251312809 Cr

Could GM technology produce the next generation of poultry vaccines?

Genetic engineering could unlock a new generation of vaccines that have the potential to tackle major poultry diseases more quickly and effectively, scientists say.

Researchers at the UK’s Pirbright Institute have harnessed genetically modified (GM) technology to develop a vaccine that targets Marek’s disease more accurately and efficiently, reports Poultry World.

And they say the techniques they used to develop it could be replicated to fight other diseases, potentially saving poultry producers millions of dollars every year.

The researchers’ claims came after they created a new technique to edit genes, helping them produce a vaccine for Marek’s disease that can target more strains of the virus that causes it than currently available vaccines.

Existing vaccines for Marek’s disease — which can lead to bird losses of up to 20% — have been developed from turkey herpes virus (HVT), using a complicated technique that does not always produce effective results.

To improve the process, scientists at Pirbright developed a gene-editing technology that allows them to target, cut and edit HVT gene sequences more accurately and easily.

They believe the technique — known as clustered regularly interspaced palindromic repeats — could be replicated to produce a new generation of more effective poultry vaccinations.

Yongxiu Yao, one of scientists behind the project, said: “HVT is widely used in the production of a variety of avian disease vaccines.

“Genetically engineering it in this way has unlocked its potential to protect against all strains of Marek’s disease virus, as well as other dangerous avian viruses such as bird flu, which is also a danger to humans.

“More cost-effective and efficient vaccines will help protect both avian and human health and potentially deliver major social and economic benefits in the UK and across the world.”

Full article




Posted on February 16, 2017

tags: , ,
RELATED NEWS



You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.